Sie suchten nach: stemi (Estnisch - Englisch)

stemi
stemi

Ägeda stemi raviks.
for treatment of acute stemi:

Ägeda stemi-ga patsientide ravi
treatme nt in patients with acute stemi

6036 stemi acs ravi saanud patsiendil.
6,036 patients undergoing treatment of stemi acs.

stemi populatsioonis märkimisväärseid erinevusi ei olnud.
no significant difference was seen in the stemi population.

st segmendi elevatsiooniga müokardiinfarkti (stemi) ravi
treatment of st segment elevation myocardial infarction (stemi)

st- segmendi elevatsiooniga müokardiinfarkti (stemi) ravi üü
in this subgroup, the incidence of major bleeding on fondaparinux and enoxaparin at day 9 was 2.2% and 5.0% respectively (hazard ratio 0.43, 95% ci, 0.33; 0.57).

kõik patsiendid said stemi standardravi, sealhulgas esmane pci m
treatment of st segment elevation myocardial infarction (stemi) oasis 6 was a double blind, randomised study assessing the safety and efficacy of fondaparinux 2.5 mg once daily, versus usual care (placebo (47%) or ufh (53%)) in approximately 12000 patients with stemi.

intravenoosne manustamine (esimene annus ainult stemi patsientidel)
intravenous administration (first dose in patients with stemi only)

verejooks oli ua/nstemi ja stemi patsientidel sageli kirjeldatud kõrvaltoime.
bleeding was a commonly reported event in patients with ua/nstemi and stemi.

q-sakita müokardiinfarkti; 10 176 patsienti said enoksapariini ägeda stemi raviks.
10,176 patients receiving enoxaparin in the treatment of acute st segment elevation myocardial infarction.

ua/ nstemi ja stemi raviks tuleb fondapariinuksit ettevaatusega kasutada patsientidel, kes saavad r
m

keskses stemi kliinilises uuringus ei alustatud fondapariinuksi uuesti manustamist varem kui 3 tundi pärast hülsi lu
in the pivotal stemi clinical no

äge koronaarsündroom (ebastabiilne stenokardia, nstemi ja stemi) (vt lõik 4.4);
an acute coronary syndrome (unstable angina, nstemi and stemi) (see section 4.4)

stemi patsientidel, kellele tehakse esmane pci, ei soovitata fondapariinuksit kasutada enne pci protseduuri või protseduuri ajal.
in stemi patients undergoing primary pci, the use of fondaparinux prior to and during pci is not recommended.

stemi või ua/ nstemi patsientidel, kellele tehakse koronaararteri šunteerimine (cabg), ei tohi üü
in stemi or ua/ nstemi patients who are to undergo coronary artery bypass graft (cabg) surgery, fondaparinux where possible, should not be given during the 24 hours before surgery and may be ct

en st segmendi elevatsiooniga müokardiinfarkti (stemi) ravi fondapariinuksi soovitatav annus on 2, 5 mg üks kord päevas.
ra the recommended dose of fondaparinux is 2.5 mg once daily.

pci ja juhtekateetri tromboseerumise risk stemi patsientidel, kellele tehakse esmane pci, ei soovitata fondapariinuksit kasutada enne pci protseduuri või protseduuri ajal.
14 pci and risk of guiding catheter thrombus in stemi patients undergoing primary pci, the use of fondaparinux prior to and during pci is not recommended.

stemi-ga patsiente, kellele planeeritakse esmane perkutaanne koronaarinterventsioon võib randomiseerida 12 tunni jooksul pärast sümptomite ilmnemist ka ilma eelneva koronarograafiata.
patients with stemi within 12 hours of symptoms and planned for primary pci could be randomised without knowledge of coronary anatomy.

st-segmendi elevatsiooniga müokardiinfarkti (stemi) ravi patsientidel, kes saavad trombolüütikume või kes ei saa esialgu muud reperfusioonravi.
treatment of st segment elevation myocardial infarction (stemi) in patients who are managed with thrombolytics or who initially are to receive no other form of reperfusion therapy.